LLY-283

LLY-283

CAT N°: 21596
Price:

From 48.00 40.80

LLY-283 is an inhibitor of protein arginine methyltransferase 5 (PRMT5; IC50 = 22 nM).{43789} It is selective for PRMT5 over a panel of methyltransferases, including PRMT4, -6, and -7 at 1 ?M. It reduces symmetric demethylation of SmBB’ in MCF-7 cells (IC50 = 25 nM) and inhibits proliferation of various breast, gastric, hematological, lung, skin, and ovarian cancer cell lines (IC50s = 3-30 nM). LLY-283 (20 mg/kg) inhibits tumor growth in an A375 mouse xenograft model. It also disrupts alternative splicing events in, and inhibits proliferation and self-renewal of, patient-derived glioblastoma stem cells and increases survival in an orthotopic patient-derived xenograft (PDX) mouse model.{58352} See the Structural Genomics Consortium (SGC) website for more information.

We also advise you